AI Technology for People
On Wednesday 25 September, Executive Board President Geert ten Dam joined with Mayor of Amsterdam Femke Halsema and the presidents of the Amsterdam University Medical Centre (UMC), the Vrije Universiteit (VU), the Netherlands Cancer Institute (NKI)/ Antoni van Leeuwenhoek Hospital, Sanquin and the Amsterdam Economic Board to sign a memorandum of understanding (MoU) on collaboration in the field of Life Sciences & Health (LSH) and Artificial Intelligence (AI).
Mayor Halsema with Frida van den Maagdenberg (Amsterdam UMC), Geert ten Dam (UvA), Mirjam van Praag (VU), Nina Tellegen (Amsterdam Economic Board) and René van Lier (Sanquin). Photo: Brenda de Vries
Amsterdam is the perfect city for an LSH hub. In the Amsterdam metropolitan area there are already 300 companies working in the Life Sciences & Health sector and the number is still growing, helped by, among other things, the arrival of the European Medicines Agency and Brexit. Amsterdam has high-level institutions such as the two hospitals mentioned above, UMC and NKI/ Antoni van Leeuwenhoek. In addition, Amsterdam has an excellent position on which to build in the area of Data Science and AI, given the research and knowledge bases at the UvA and the VU. The bringing together of these two distinctive strengths of Amsterdam – LSH and Data Sciences/AI – has enormous potential. Furthermore, Amsterdam has an attractive business climate for international companies, with good international accessibility (through Schiphol airport, among other things), the availability of talent, high internet speeds, a focus on startups and innovation, and a high quality of life.
But, with all the competition internationally, such a hub is not going to happen on its own. Therefore, the city of Amsterdam is working with the UvA, VU, UMC, NKI/ Antoni van Leeuwenhoek Hospital, Sanquin, the Amsterdam Economic Board and other companies to make Amsterdam the standout choice for LSH companies in the Netherlands, by strengthening the climate for business and innovation and by attracting, training and retaining talent.
Data and AI are becoming increasingly important within the LSH sector. The number of innovative companies that process large amounts of data and use it to improve care continues to grow. This is done not only through work on new medicines, but, for example, also through a focus on lifestyle and prevention. The MoU is aimed at increasing cooperation in the field of LSH and AI.
Executive Board President Geert ten Dam: ‘In order to innovate in the field of Life Sciences & Health, AI research and the availability of data are essential. We are fully committed to attracting, training and retaining the talent needed for this. The close cooperation between the medical centres and AI researchers is a great example of ‘AI technology for people’.’ The UvA’s Informatics Institute is planning to set up a new “ELLIS Unit” – the European Laboratory for Learning and Intelligent Systems is an initiative aimed at keeping in Europe talent in machine learning and AI research fields.
The MoU contains agreements to work on:
Sem Vijverberg – PhD Candidate at Vrije Universiteit Amsterdam – and University of Amsterdam PostDoc researcher Tijmen Bakker have been selected as participants in the Faculty of Impact, and will be taking part in an intensive two year program where ten ambitious scientists work with each other and with a selection of experts to conquer […]News
Every language contains riddles and secrets, currently there are seven thousand+ known languages. A treasure trove of colourful, curious and enigmatic stories. Every language tells a story about and gives a picture of the culture and the people that speak or have spoken this language. And every language is full of riddles and secrets that […]News
Anya Biotech, representing Amsterdam UMC, has won the second edition of the Proefdiervrij Venture Challenge on the 22nd of April 2022. Their winning innovation is based on research from the Department of Medical Biology at the AMC. The team takes home €25.000, – in prize money to kick-start their venture based on human heart models […]News